Literature DB >> 23846127

Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults.

James E Turner1, John P Campbell, Kate M Edwards, Lauren J Howarth, Graham Pawelec, Sarah Aldred, Paul Moss, Mark T Drayson, Victoria E Burns, Jos A Bosch.   

Abstract

Ageing is associated with a decline in immune competence termed immunosenescence. In the elderly, this process results in an accumulation of differentiated 'effector' phenotype memory T cells, predominantly driven by Cytomegalovirus (CMV) infection. Here, we asked whether CMV also drives immunity towards a senescent profile in healthy young adults. One hundred and fifty-eight individuals (mean ± SD; age 21 ± 3 years, body mass index 22.7 ± 2.7 kg m(2)) were assessed for CMV serostatus, the numbers/proportions of CD4(+) and CD8(+) late differentiated/effector memory cells (i.e. CD27(-)CD28(-)/CD45RA(+)), plasma interleukin-6 (IL-6) and antibody responses to an in vivo antigen challenge (half-dose influenza vaccine). Thirty percent (48/158) of participants were CMV(+). A higher lymphocyte and CD8(+) count (both p < 0.01) and a lower CD4/CD8 ratio (p < 0.03) were observed in CMV(+) people. Eight percent (4/58) of CMV(+) individuals exhibited a CD4/CD8 ratio <1.0, whereas no CMV(-) donor showed an inverted ratio (p < 0.001). The numbers of CD4(+) and CD8(+)CD27(-)CD28(-)/CD45RA(+) cells were ~ fourfold higher in CMV(+) people (p < 0.001). Plasma IL-6 was higher in CMV(+) donors (p < 0.05) and showed a positive association with the numbers of CD8(+)CD28(-) cells (p < 0.03). Finally, there was a significant negative correlation between vaccine-induced antibody responses to the A/Brisbane influenza strain and CMV-specific immunoglobulin G titres (p < 0.05). This reduced vaccination response was associated with greater numbers of total CD8(+) and CD4(+) and CD8(+)CD27(-)CD28(-)/CD45RA(+) cells (p < 0.05). This study observed marked changes in the immune profile of young adults infected with CMV, suggesting that this virus may underlie rudimentary aspects of immunosenescence even in a chronologically young population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846127      PMCID: PMC3889879          DOI: 10.1007/s11357-013-9557-4

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  61 in total

Review 1.  CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity.

Authors:  R Cortesini; J LeMaoult; R Ciubotariu; N S Cortesini
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

2.  Interleukin-6 production by endothelial cells after infection with influenza virus and cytomegalovirus.

Authors:  F L Visseren; M S Verkerk; K P Bouter; R J Diepersloot; D W Erkelens
Journal:  J Lab Clin Med       Date:  1999-12

Review 3.  The role of CD8+ T-cell replicative senescence in human aging.

Authors:  Rita B Effros; Mirabelle Dagarag; Carolyn Spaulding; Janice Man
Journal:  Immunol Rev       Date:  2005-06       Impact factor: 12.988

4.  Association between obesity and vulnerability and serologic response to influenza vaccination in older adults.

Authors:  H K Talbot; L A Coleman; K Crimin; Y Zhu; M T Rock; J Meece; D K Shay; E A Belongia; M R Griffin
Journal:  Vaccine       Date:  2012-04-03       Impact factor: 3.641

5.  Latent cytomegalovirus infection amplifies CD8 T-lymphocyte mobilisation and egress in response to exercise.

Authors:  James E Turner; Sarah Aldred; Oliver C Witard; Mark T Drayson; Paul M Moss; Jos A Bosch
Journal:  Brain Behav Immun       Date:  2010-07-16       Impact factor: 7.217

6.  Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals.

Authors:  S Chidrawar; N Khan; W Wei; A McLarnon; N Smith; L Nayak; P Moss
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

7.  Intracellular infections enhance interleukin-6 and plasminogen activator inhibitor 1 production by cocultivated human adipocytes and THP-1 monocytes.

Authors:  J J M Bouwman; R J A Diepersloot; F L J Visseren
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

8.  Immunosenescence and Cytomegalovirus: where do we stand after a decade?

Authors:  Graham Pawelec; Arne Akbar; Peter Beverley; Calogero Caruso; Evelyna Derhovanessian; Tamas Fülöp; Paul Griffiths; Beatrix Grubeck-Loebenstein; Klaus Hamprecht; Gerhard Jahn; Florian Kern; Sven D Koch; Anis Larbi; Andrea B Maier; Derek Macallan; Paul Moss; Sandrine Samson; Jan Strindhall; Emanuelle Trannoy; Mark Wills
Journal:  Immun Ageing       Date:  2010-09-07       Impact factor: 6.400

9.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

10.  Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors.

Authors:  María Luisa Pita-Lopez; Inmaculada Gayoso; Olga DelaRosa; Javier G Casado; Corona Alonso; Elisa Muñoz-Gomariz; Raquel Tarazona; Rafael Solana
Journal:  Immun Ageing       Date:  2009-08-28       Impact factor: 6.400

View more
  32 in total

Review 1.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Cytomegalovirus infection enhances the immune response to influenza.

Authors:  David Furman; Vladimir Jojic; Shalini Sharma; Shai S Shen-Orr; Cesar J L Angel; Suna Onengut-Gumuscu; Brian A Kidd; Holden T Maecker; Patrick Concannon; Cornelia L Dekker; Paul G Thomas; Mark M Davis
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

Review 3.  T-cell aging in rheumatoid arthritis.

Authors:  Cornelia M Weyand; Zhen Yang; Jörg J Goronzy
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

4.  How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Authors:  Allison E Aiello; Yen-Ling Chiu; Daniela Frasca
Journal:  Geroscience       Date:  2017-06-18       Impact factor: 7.713

5.  Childhood environments and cytomegalovirus serostatus and reactivation in adults.

Authors:  Denise Janicki-Deverts; Sheldon Cohen; William J Doyle; Anna L Marsland; Jos Bosch
Journal:  Brain Behav Immun       Date:  2014-03-25       Impact factor: 7.217

6.  Understanding the mechanism of action of cytomegalovirus-induced regulatory T cells.

Authors:  Adriana Tovar-Salazar; Adriana Weinberg
Journal:  Virology       Date:  2020-05-10       Impact factor: 3.616

Review 7.  The silent war of CMV in aging and HIV infection.

Authors:  Rita B Effros
Journal:  Mech Ageing Dev       Date:  2015-09-25       Impact factor: 5.432

8.  Persistent Herpesvirus Infections and Telomere Attrition Over 3 Years in the Whitehall II Cohort.

Authors:  Jennifer B Dowd; Jos A Bosch; Andrew Steptoe; Bamini Jayabalasingham; Jue Lin; Robert Yolken; Allison E Aiello
Journal:  J Infect Dis       Date:  2017-09-01       Impact factor: 5.226

9.  Does cytomegalovirus infection contribute to socioeconomic disparities in all-cause mortality?

Authors:  Lydia Feinstein; Christian E Douglas; Rebecca C Stebbins; Graham Pawelec; Amanda M Simanek; Allison E Aiello
Journal:  Mech Ageing Dev       Date:  2016-06-04       Impact factor: 5.432

10.  TTV DNA plasma load and its association with age, gender, and HCMV IgG serostatus in healthy adults.

Authors:  Mats Haloschan; Rainer Bettesch; Irene Görzer; Lukas Weseslindtner; Michael Kundi; Elisabeth Puchhammer-Stöckl
Journal:  Age (Dordr)       Date:  2014-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.